PRIMARY BILIARY CIRRHOSIS, PRIMARY SCLEROSING CHOLANGITIS, AND AUTOIMMUNE CHOLANGITIS

Aadland, 1987, Primary sclerosing cholangitis: A long term follow-up study, Scand J Gastroenterol, 22, 655, 10.3109/00365528709011139 Ahrens, 1950, Primary biliary cirrhosis, Medicine (Baltimore), 29, 299, 10.1097/00005792-195012000-00002 Balan, 1993, Histological evidence for recurrence or primary biliary cirrhosis after liver transplantation, Hepatology, 18, 1392, 10.1002/hep.1840180617 Ben-Ari, 1993, Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis, Hepatology, 18, 10, 10.1002/hep.1840180103 Bergasa, 1995, The pruritus of cholestasis: Potential pathogenic and therapeutic implications of opioids, Gastroenterology, 108, 1582, 10.1016/0016-5085(95)90709-2 Bergasa, 1998, Open-label trial of oral Nalmefene for the pruritus of cholestasis, Hepatology, 27, 679, 10.1002/hep.510270307 Boberg, 1994, Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified small-duct primary sclerosing cholangitis, Scand J Gastroenterol, 29, 744, 10.3109/00365529409092504 Bodenheimer, 1983, Elevated circulating immune complexes in primary sclerosing cholangitis, Hepatology, 3, 150, 10.1002/hep.1840030203 Brind, 1995, Prevalence and pattern of familial disease in primary biliary cirrhosis, Gut, 36, 615, 10.1136/gut.36.4.615 Broome, 1995, Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential, Hepatology, 22, 1404 Broome, 1996, Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis, Gut, 38, 610, 10.1136/gut.38.4.610 Campbell, 1998, Biliary tract carcinoma complicating primary sclerosing cholangitis: Evaluation with CT, cholangiography, US and MR imaging, Radiology, 207, 41, 10.1148/radiology.207.1.9530297 Cangemi, 1989, Effect of procto-colectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis, Gastroenterology, 96, 790, 10.1016/S0016-5085(89)80078-2 Cauch-Dudek, 1998, Fatigue in primary biliary cirrhosis, Gut, 43, 705, 10.1136/gut.43.5.705 Chapman, 1980, Primary sclerosing cholangitis—a review of its clinical features, cholangiography and hepatic histology, Gut, 21, 870, 10.1136/gut.21.10.870 Chazouilleres, 1998, Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy, Hepatology, 28, 296, 10.1002/hep.510280203 Chen, 1997, Primary biliary cirrhosis associated with mixed type autoimmune hemolytic anemia and sicca syndrome: A case report and review of literature, Am J Gastroenterol, 92, 1547 Dickson, 1989, Prognosis in primary biliary cirrhosis: Model for decision making, Hepatology, 10, 1, 10.1002/hep.1840100102 Dickson, 1992, Primary sclerosing cholangitis refinement and validation of survival models, Gastroenterology, 103, 1893, 10.1016/0016-5085(92)91449-E Donaldson, 1991, Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis, Hepatology, 13, 129, 10.1002/hep.1840130119 Ernst, 1998, MR cholangiography in primary sclerosing cholangitis, Am J Roentgenol, 171, 1027, 10.2214/ajr.171.4.9762990 Farges, 1995, Primary sclerosing cholangitis: Liver transplantation or biliary surgery, Surgery, 117, 146, 10.1016/S0039-6060(05)80078-9 Farrant, 1991, Natural history and prognostic variables in primary sclerosing cholangitis, Gastroenterology, 100, 1710, 10.1016/0016-5085(91)90673-9 Feizi, 1972, Mitochondrial and other tissue antibodies in relatives of patients with biliary cirrhosis, Clin Exp Immunol, 10, 609 Flannery, 1989, Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens, Hepatology, 10, 370, 10.1002/hep.1840100321 Galbraith, 1974, High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis, N Engl J Med, 290, 63, 10.1056/NEJM197401102900201 Gogos, 1999, Autoimmune cholangitis in a patient with celiac disease: A case report and review of the literature, J Hepatol, 30, 321, 10.1016/S0168-8278(99)80079-8 Goodman, 1995, Autoimmune cholangitis: A variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases, Dig Dis Sci, 40, 1232, 10.1007/BF02065530 Guanaben, 1997, Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: Preliminary results after 2 years, Gastroenterology, 113, 219, 10.1016/S0016-5085(97)70098-2 Haagsma, 1993, Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis, J Hepatol, 19, 8, 10.1016/S0168-8278(05)80170-9 Harada, 1997, In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset, Hepatology, 25, 791, 10.1002/hep.510250402 Harrison, 1994, Fibrous and obliterative cholangitis in liver allografts: Evidence of recurrent primary sclerosing cholangitis, Hepatology, 20, 356, 10.1002/hep.1840200214 Hendrickse, 1997, Low-dose methotrexate in primary biliary cirrhosis. Long-term results of a placebo-controlled trial, Hepatology, 26, 248A Hobson, 1988, Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis, Gastroenterology, 94, 1006, 10.1016/0016-5085(88)90560-4 Holdsworth, 1965, Ulcerative colitis in chronic liver disease, QJM, 34, 211 Hopf, 1989, Relation between Escherichia coli R (rough) forms in gut, and in liver, and primary biliary cirrhosis, Lancet, 2, 1419, 10.1016/S0140-6736(89)92034-5 Howard, 1998, Three-dimensional structure of the major autoantigen in primary biliary cirrhosis, Gastroenterology, 115, 139, 10.1016/S0016-5085(98)70375-0 Howell, 1992, Endoscopic needle aspiration biopsy at ERCP in the diagnosis of biliary strictures, Gastrointest Endosc, 38, 531, 10.1016/S0016-5107(92)70510-0 Jones, 1997, Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes, Hepatology, 26, 1138, 10.1002/hep.510260508 Joplin, 1994, Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary eipthelium from patients with primary biliary cirrhosis, Hepatology, 19, 1375, 10.1002/hep.1840190610 Kaplan, 1997, Toward better treatment of primary sclerosing cholangitis, N Engl J Med, 336, 719, 10.1056/NEJM199703063361009 Keiding, 1998, Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography, Hepatology, 28, 700, 10.1002/hep.510280316 Kilmurrey, 1996, Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?, Hepatology, 23, 1148 Kim, 1998, Optimal timing of liver transplantation for primary biliary cirrhosis, Hepatology, 28, 33, 10.1002/hep.510280106 Kingham, 1998, The association between primary biliary cirrhosis and coeliac disease: A study of relevant prevalences, Gut, 42, 120, 10.1136/gut.42.1.120 Kono, 1988, Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits, Gastroenterology, 94, 787, 10.1016/0016-5085(88)90255-7 Kurzawinski, 1993, A prospective study of biliary cytology in 100 patients with bile duct strictures, Hepatology, 18, 1399, 10.1002/hep.1840180618 Lee, 1995, Primary sclerosing cholangitis, N Engl J Med, 21, 661 Leuschner, 1996, Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis, J Hepatol, 25, 49, 10.1016/S0168-8278(96)80327-8 Lichtman, 1990, Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth, Gastroenterology, 98, 414, 10.1016/0016-5085(90)90833-M Lindor, 1997, Ursodiol for primary sclerosing cholangitis, N Engl J Med, 336, 691, 10.1056/NEJM199703063361003 Lindor, 1994, Ursodeoxycholic acid in the treatment of primary biliary cirrhosis, Gastroenterology, 106, 1284, 10.1016/0016-5085(94)90021-3 Lindor, 1990, Advances in primary sclerosing cholangitis, Am J Med, 89, 73, 10.1016/0002-9343(90)90101-I Loftus, 1998, Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation, Hepatology, 27, 685, 10.1002/hep.510270308 Loftus, 1996, Risk of colorectal neoplasia in patients with primary sclerosing cholangitis, Gastroenterology, 110, 432, 10.1053/gast.1996.v110.pm8566590 Long, 1977, Presentation and course of asymptomatic primary biliary cirrhosis, Gastroenterology, 72, 1204, 10.1016/S0016-5085(77)80011-5 MacCarty, 1983, Primary sclerosing cholangitis: Findings on cholangiography and pancreatography, Radiology, 149, 39, 10.1148/radiology.149.1.6412283 Mandal, 1994, Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium, Gastroenterology, 106, 185, 10.1016/S0016-5085(94)95271-X Martinez, 1995, Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis, Hepatology, 21, 113 Mason, 1998, Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders, Lancet, 351, 1620, 10.1016/S0140-6736(97)10290-2 Masumoto, 1998, Three patients with autoimmune cholangiopathy treated with prednisolone, J Gastroenterol, 33, 909, 10.1007/s005350050199 Mehal, 1994, HLR DR4 is a marker for rapid disease progression in primary sclerosing cholangitis, Gastroenterology, 106, 160, 10.1016/S0016-5085(94)95085-7 Metcalf, 1996, Natural history of primary biliary cirrhosis, Lancet, 348, 1399, 10.1016/S0140-6736(96)04410-8 Michieletti, 1994, Antimitochondrial antibody negative primary biliary cirrhosis. A distinct syndrome of autoimmune cholangitis, Gut, 35, 260, 10.1136/gut.35.2.260 Minuk, 1986, Reticulo-endothelial system Fc receptor-mediated clearance of IgG tagged erythrocytes from the circulation of patients with idiopathic ulcerative colitis and chronic liver disease, Hepatology, 6, 1, 10.1002/hep.1840060102 Mistilis, 1965, Pericholangitis and ulcerative colitis. Pathology, etiology and pathogenesis, Ann Intern Med, 63, 1, 10.7326/0003-4819-63-1-1 Nakamura, 1997, Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis, Am J Gastroenterol, 92, 2245 Nashan, 1996, Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation, Hepatology, 23, 1105, 10.1002/hep.510230526 Neuberger, 1999, PBC and AMA–what is the connection?, Hepatology, 29, 271, 10.1002/hep.510290126 Nichols, 1993, Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis, Mayo Clin Proc, 68, 874, 10.1016/S0025-6196(12)60696-X O'Donohue, 1998, Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis, J Hepatol, 28, 433, 10.1016/S0168-8278(98)80317-6 Okuno, 1987, Chronic active hepatitis with histological features of primary biliary cirrhosis, Dig Dis Sci, 32, 775, 10.1007/BF01296147 Olsson, 1991, Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis, Gastroenterology, 100, 1319, 10.1016/0016-5085(91)70019-T 1997, Pares A for the Spanish Association for the Study of the Liver: Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: Results of a randomized, double-blind, placebo-controlled trial, J Hepatol, 26, 166 Pasha, 1999, Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis, Hepatology, 29, 21, 10.1002/hep.510290116 Porayko, 1990, Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease, Gastroenterology, 98, 1594, 10.1016/0016-5085(90)91096-O Poupon, 1997, Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis, Gastroenterology, 113, 884, 10.1016/S0016-5085(97)70183-5 Poupon, 1994, Ursodiol for the long-term treatment of primary biliary cirrhosis, N Engl J Med, 330, 1342, 10.1056/NEJM199405123301903 Rahn, 1983, CT appearance of sclerosing cholangitis, Am J Roentgenol, 141, 549, 10.2214/ajr.141.3.549 Rasmussen, 1997, Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease, Scand J Gastroenterol, 32, 604, 10.3109/00365529709025107 Ricci, 1997, A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease, Hepatology, 25, 672, 10.1002/hep.510250330 Rosen, 1995, Bones and primary biliary cirrhosis, Hepatology, 21, 253, 10.1002/hep.1840210138 Rubin, 1965, Primary biliary cirrhosis: Chronic non-suppurative destructive cholangitis, Am J Pathol, 46, 387 Sadamoto, 1998, Expression of pyruvate-dehydrogenase complex PDC-E-2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis, Lancet, 352, 1595, 10.1016/S0140-6736(05)61042-2 Scheuer, 1967, Primary biliary cirrhosis, Proceedings of the Royal Society of Medicine, 60, 1257, 10.1177/003591576706001205 Schrumpf, 1994, Risk factors in primary sclerosing cholangitis, J Hepatol, 21, 1061, 10.1016/S0168-8278(05)80618-X Seibold, 1992, Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis, Gut, 33, 657, 10.1136/gut.33.5.657 Shapiro, 1979, Serum bilirubin: A prognostic factor in primary biliary cirrhosis, Gut, 20, 137, 10.1136/gut.20.2.137 Sherlock, 1998, Autoimmune cholangitis: A unique entity?, Mayo Clin Proc, 73, 184, 10.1016/S0025-6196(11)63653-7 Sherlock, 1998, Overview of chronic cholestatic conditions in adults. Terminology and definitions, Clinics in Liver Disease, 2, 217, 10.1016/S1089-3261(05)70004-0 Sherlock, 1994, Therapeutic trials in primary biliary cirrhosis, QJM, 87, 701 Sherlock, 1997, Primary biliary cirrhosis, 239 Stemerowicz, 1988, Are antimitochondrial antibodies in primary biliary cirrhosis induced by R (rough) mutants of enterobacteriacea?, Lancet, 2, 1166, 10.1016/S0140-6736(88)90235-8 Steckman, 1990, Hepatobiliary disease that precedes ulcerative colitis, J Clin Gastroenterol, 6, 425, 10.1097/00004836-198410000-00006 Shetty, 1997, The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis, Hepatology, 25, 1049, 10.1002/hep.510250501 Stone, 1998, Genomic associations in AMA-positive and AMA-negative primary biliary cirrhosis [abstract], Gastroenterology, 116, A-585 Swain, 1998, Chronic cholestasis in rats induces amhedonia and loss of social interest, Hepatology, 28, 6, 10.1002/hep.510280102 Terjung, 1998, Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins, Hepatology, 28, 332, 10.1002/hep.510280207 Tzakis, 1989, Liver transplantation for primary biliary cirrhosis, Semin Liver Dis, 9, 144, 10.1055/s-2008-1040506 Van de Water, 1996, Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis, Hepatology, 24, 1079, 10.1002/hep.510240517 Van Hoogstraten, 1998, Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses, J Hepatol, 29, 417, 10.1016/S0168-8278(98)80059-7 Vilagut, 1994, Mycobacterium Gordonae DNA in liver tissue of patients with primary biliary cirrhosis, J Hepatol, 21, 587, 10.1016/S0168-8278(94)80117-7 Walker, 1965, Serological tests in diagnosis of primary biliary cirrhosis, Lancet, 1, 827, 10.1016/S0140-6736(65)91372-3 Weber, 1998, Detection of retroviral antibodies in primary biliary cirrhosis [letter], Lancet, 352, 149, 10.1016/S0140-6736(98)85060-5 Wiesner, 1989, Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis, Hepatology, 10, 430, 10.1002/hep.1840100406 Wiesner, 1986, Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis, Gastroenterology, 90, 316, 10.1016/0016-5085(86)90926-1 Weissman, 1983, Intestinal lung disease in primary biliary cirrhosis, Am J Med Sci, 285, 21, 10.1097/00000441-198305000-00004 White, 1987, Primary sclerosing cholangitis, Am J Surg, 153, 439, 10.1016/0002-9610(87)90786-0 Wilschanski, 1995, Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, Hepatology, 22, 1415